US Patent Litigations are now available. Check here

Explore Staidson Beijing Biopharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3287139Aug 11, 2021Nerve Growth Factor Composition And Powder Injection2
EP3287140Jun 2, 2021Nerve Growth Factor Composition And Powder Injection2